Lowentritt Lowentritt B B Pilon Pilon D D Khilfeh Khilfeh I I Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: a comparison of patients initiated on apalutamide or enzalutamide Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: a comparison of patients initiated on apalutamide or enzalutamide Urol Oncol Urol Oncol 2023 2023 41 41 5 5 253.e1 253.e1 253.e9 253.e9 10.1016/j.urolonc.2023.03.003 10.1016/j.urolonc.2023.03.003 supplied-pmid 37061452? This evidence concerns the gene KLK3 and prostate cancer.